Homogeneous time-resolved fluorescence-based assay to screen for ligands targeting the growth hormone secretagogue receptor type 1a
Jean-Philippe Leyris, Thomas Roux, Eric Trinquet et al. · Analytical Biochemistry · 2010
Cited by 86 works. doi:10.1016/j.ab.2010.09.030
Authors
- Jean-Philippe Leyris
- Thomas Roux
- Eric Trinquet
- Pascal Verdié
- Jean‐Alain Fehrentz
- Nadia Oueslati
- Stéphanie Douzon
- Emmanuel Bourrier
- Laurent Lamarque
- Didier Gagne
- Jean‐Claude Galleyrand
- Céline M’Kadmi
- Jean Martínez
- Sophie Mary
- Jean‐Louis Banères
- Jacky Marie
References
- THE PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY
- Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
- How many drug targets are there?
- The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
- Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin
- Structural diversity of G protein-coupled receptors and significance for drug discovery
- Probing molecular interactions with homogeneous techniques based on rare earth cryptates and fluorescence energy transfer
- Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.
- High Constitutive Signaling of the Ghrelin Receptor—Identification of a Potent Inverse Agonist